Substance and product data management services
Submitted by Anonymous (not verified) on 8 December 2025 - 8:40
Substance and product data management services
Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)
Submitted by Anonymous (not verified) on 8 December 2025 - 8:32
Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)
Remsima
Submitted by Anonymous (not verified) on 8 December 2025 - 8:30
Remsima
Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 19, Status: Authorised
Submitted by Anonymous (not verified) on 5 December 2025 - 15:15
Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Date of authorisation: 08/01/2018, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 5 December 2025 - 14:52
Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Date of authorisation: 08/01/2018, Revision: 15, Status: Authorised
Agenda - HMA/EMA Annual Data Forum 2025
Submitted by Anonymous (not verified) on 5 December 2025 - 14:45
Agenda - HMA/EMA Annual Data Forum 2025
Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised
Submitted by Anonymous (not verified) on 5 December 2025 - 14:45
Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised
Submitted by Anonymous (not verified) on 5 December 2025 - 14:35
Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Voraxaze, glucarpidase, Date of authorisation: 11/01/2022, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 5 December 2025 - 14:15
Human medicines European public assessment report (EPAR): Voraxaze, glucarpidase, Date of authorisation: 11/01/2022, Revision: 2, Status: Authorised
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 2-4 December 2025
Submitted by Anonymous (not verified) on 5 December 2025 - 13:26
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 2-4 December 2025